Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 12:25PM ET
0.4600
Dollar change
+0.0100
Percentage change
2.22
%
Index- P/E- EPS (ttm)-1.13 Insider Own41.33% Shs Outstand8.93M Perf Week-1.08%
Market Cap4.18M Forward P/E- EPS next Y- Insider Trans0.48% Shs Float5.32M Perf Month-4.66%
Income-10.19M PEG- EPS next Q- Inst Own4.31% Short Float0.38% Perf Quarter-17.86%
Sales10.31M P/S0.41 EPS this Y- Inst Trans22.55% Short Ratio0.44 Perf Half Y-47.73%
Book/sh1.40 P/B0.33 EPS next Y- ROA-46.05% Short Interest0.02M Perf Year-70.13%
Cash/sh0.62 P/C0.74 EPS next 5Y15.00% ROE-57.99% 52W Range0.40 - 2.05 Perf YTD-8.11%
Dividend Est.- P/FCF- EPS past 5Y-9.21% ROI-79.72% 52W High-77.51% Beta1.82
Dividend TTM- Quick Ratio2.59 Sales past 5Y29.42% Gross Margin38.62% 52W Low15.00% ATR (14)0.03
Dividend Ex-Date- Current Ratio2.59 EPS Y/Y TTM1.71% Oper. Margin-101.22% RSI (14)49.29 Volatility6.01% 6.91%
Employees75 Debt/Eq0.02 Sales Y/Y TTM3.25% Profit Margin-98.75% Recom1.00 Target Price5.00
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q33.21% Payout- Rel Volume0.60 Prev Close0.45
Sales Surprise24.29% EPS Surprise34.29% Sales Q/Q7.52% EarningsNov 02 BMO Avg Volume46.21K Price0.46
SMA202.03% SMA50-5.00% SMA200-45.65% Trades Volume13,346 Change2.22%
Jan-23-24 07:30AM
Jan-22-24 04:15PM
Jan-18-24 08:11AM
Dec-07-23 07:30AM
Nov-05-23 11:01AM
07:30AM Loading…
Nov-02-23 07:30AM
Oct-26-23 07:30AM
Oct-23-23 07:30AM
Sep-28-23 07:30AM
Sep-16-23 01:01AM
Sep-13-23 07:30AM
Sep-07-23 02:07PM
Sep-06-23 04:05PM
Aug-30-23 07:30AM
Aug-16-23 07:30AM
07:30AM Loading…
Aug-09-23 07:30AM
Aug-07-23 06:02AM
Aug-02-23 07:00AM
Jul-25-23 07:30AM
Jul-06-23 07:30AM
May-23-23 07:30AM
May-04-23 07:00AM
Apr-24-23 07:30AM
Apr-20-23 07:00AM
Apr-18-23 06:26AM
Mar-17-23 04:56AM
Mar-14-23 10:21PM
07:00AM
Mar-02-23 07:00AM
Feb-28-23 04:02PM
07:30AM Loading…
Feb-08-23 07:30AM
Jan-24-23 11:00AM
07:30AM
Jan-23-23 07:30AM
Jan-19-23 07:30AM
Jan-10-23 01:11PM
Dec-05-22 07:30AM
Nov-08-22 07:00AM
Oct-27-22 08:43AM
07:30AM
Oct-25-22 07:30AM
Oct-18-22 07:30AM
Oct-04-22 07:30AM
Sep-29-22 05:25AM
Sep-22-22 04:15PM
Aug-31-22 07:30AM
Aug-07-22 08:17AM
Aug-04-22 07:00AM
Jul-21-22 07:30AM
Jul-07-22 11:03AM
07:30AM
Jun-08-22 08:49AM
07:30AM
May-19-22 07:30AM
May-16-22 07:30AM
May-10-22 07:00AM
May-02-22 07:30AM
Apr-26-22 07:30AM
Apr-13-22 07:30AM
Mar-15-22 07:30AM
Mar-08-22 07:30AM
Feb-24-22 06:44AM
Feb-17-22 07:39AM
Feb-10-22 07:30AM
Feb-03-22 07:30AM
Jan-13-22 08:00AM
Jan-04-22 01:46PM
12:39PM
08:00AM
Dec-16-21 08:00AM
Dec-02-21 07:00AM
Dec-01-21 09:24PM
Nov-29-21 12:03AM
Nov-27-21 07:47AM
Nov-22-21 11:23AM
08:00AM
04:55AM
Nov-04-21 07:00AM
Nov-01-21 08:00AM
Oct-21-21 08:00AM
Oct-07-21 08:00AM
Sep-14-21 08:00AM
Sep-01-21 08:30AM
Aug-18-21 07:00AM
Aug-12-21 09:00AM
Aug-10-21 07:00AM
Jul-29-21 07:50AM
Jul-27-21 07:00AM
Jul-01-21 11:18AM
Jun-21-21 02:20PM
Jun-16-21 07:05PM
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bielak BenjaminChief Info Officer & SecretarySep 14Buy0.7218,00012,96084,348Sep 15 04:23 PM
Curley TracyCEO, CFO and TreasurerMay 31Buy1.254,4005,50049,541Jun 01 05:56 PM